Austar Lifesciences Buys Out Partner in Steris Joint Venture

MT Newswires Live

2024/12/17

Austar Lifesciences (HKG:6118) subsidiary Austar Equipment bought the 51% stake of its joint venture partner in STERIS-AUSTAR Pharmaceutical Systems Hong Kong, giving it full ownership.

The pharmaceutical engineering solutions provider purchased the stake from Steris Mauritius, an affiliate of NYSE-listed Steris, for $1.5 million, according to a Monday bourse filing.

Established in 2006, the target firm is a joint venture between Austar Equipment and Steris Mauritius. The JV owns STERIS-AUSTAR Pharmaceutical Systems (Shanghai), which manufactures and sells pharmaceutical water and steam equipment in China.

Austar said it wanted full ownership of the venture because the partnership's existing cost structure has "brought challenges" to the JV's product competitiveness and business expansion.

Austar added that it entered into a technology and trademark license agreement with Steris, under which the group is authorized to produce Finn-Aqua-related products owned by Steris and continue to market them in mainland China.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2492987536"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2492987536\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2492987536?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-17 16:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492987536","market":"sh","top_or_hot":-1,"title":"Austar Lifesciences Buys Out Partner in Steris Joint Venture","media":"MT Newswires Live","content":"<html><body><p> Austar Lifesciences (HKG:6118) subsidiary Austar Equipment bought the 51% stake of its joint venture partner in STERIS-AUSTAR Pharmaceutical Systems Hong Kong, giving it full ownership.</p><p>The pharmaceutical engineering solutions provider purchased the stake from Steris Mauritius, an affiliate of NYSE-listed Steris, for $1.5 million, according to a Monday bourse filing.</p><p>Established in 2006, the target firm is a joint venture between Austar Equipment and Steris Mauritius. The JV owns STERIS-AUSTAR Pharmaceutical Systems (Shanghai), which manufactures and sells pharmaceutical water and steam equipment in China.</p><p>Austar said it wanted full ownership of the venture because the partnership's existing cost structure has \"brought challenges\" to the JV's product competitiveness and business expansion.</p><p>Austar added that it entered into a technology and trademark license agreement with Steris, under which the group is authorized to produce Finn-Aqua-related products owned by Steris and continue to market them in mainland China.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Austar Lifesciences Buys Out Partner in Steris Joint Venture</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAustar Lifesciences Buys Out Partner in Steris Joint Venture\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2024-12-17 16:09</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Austar Lifesciences (HKG:6118) subsidiary Austar Equipment bought the 51% stake of its joint venture partner in STERIS-AUSTAR Pharmaceutical Systems Hong Kong, giving it full ownership.</p><p>The pharmaceutical engineering solutions provider purchased the stake from Steris Mauritius, an affiliate of NYSE-listed Steris, for $1.5 million, according to a Monday bourse filing.</p><p>Established in 2006, the target firm is a joint venture between Austar Equipment and Steris Mauritius. The JV owns STERIS-AUSTAR Pharmaceutical Systems (Shanghai), which manufactures and sells pharmaceutical water and steam equipment in China.</p><p>Austar said it wanted full ownership of the venture because the partnership's existing cost structure has \"brought challenges\" to the JV's product competitiveness and business expansion.</p><p>Austar added that it entered into a technology and trademark license agreement with Steris, under which the group is authorized to produce Finn-Aqua-related products owned by Steris and continue to market them in mainland China.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4185","symbol_name":"保健護理機構","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2492987536","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492987536","pubTimestamp":1734422979,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Austar Lifesciences  subsidiary Austar Equipment bought the 51% stake of its joint venture partner in STERIS-AUSTAR Pharmaceutical Systems Hong Kong, giving it full ownership.The pharmaceutical engineering solutions provider purchased the stake from Steris Mauritius, an affiliate of NYSE-listed Steris, for $1.5 million, according to a Monday bourse filing.Established in 2006, the target firm is a joint venture between Austar Equipment and Steris Mauritius. The JV owns STERIS-AUSTAR Pharmaceutical Systems , which manufactures and sells pharmaceutical water and steam equipment in China.Austar said it wanted full ownership of the venture because the partnership's existing cost structure has \"brought challenges\" to the JV's product competitiveness and business expansion.Austar added that it entered into a technology and trademark license agreement with Steris, under which the group is authorized to produce Finn-Aqua-related products owned by Steris and continue to market them in mainland C","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4185":"保健护理机构","06118":"奥星生命科技","BK1141":"生命科学工具和服务","JYNT":"The Joint Corp."},"translate_title":"奥星生命科学收购Steris合资企业合作伙伴的股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06118":1,"JYNT":1},"content_text":"Austar Lifesciences (HKG:6118) subsidiary Austar Equipment bought the 51% stake of its joint venture partner in STERIS-AUSTAR Pharmaceutical Systems Hong Kong, giving it full ownership.The pharmaceutical engineering solutions provider purchased the stake from Steris Mauritius, an affiliate of NYSE-listed Steris, for $1.5 million, according to a Monday bourse filing.Established in 2006, the target firm is a joint venture between Austar Equipment and Steris Mauritius. The JV owns STERIS-AUSTAR Pharmaceutical Systems (Shanghai), which manufactures and sells pharmaceutical water and steam equipment in China.Austar said it wanted full ownership of the venture because the partnership's existing cost structure has \"brought challenges\" to the JV's product competitiveness and business expansion.Austar added that it entered into a technology and trademark license agreement with Steris, under which the group is authorized to produce Finn-Aqua-related products owned by Steris and continue to market them in mainland China.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}